| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |